Funds and ETFs Scorpius Holdings, Inc.

Equities

SCPX

US42237K4094

Pharmaceuticals

Market Closed - Nyse 04:00:00 2024-05-31 pm EDT 5-day change 1st Jan Change
0.111 USD +1.83% Intraday chart for Scorpius Holdings, Inc. +5.51% -74.79%
Scorpius Holdings, Inc., formerly NightHawk Biosciences, Inc., is an integrated contract development and manufacturing company. The Company is focused on advancing biologic and cell therapy programs to the clinic and beyond. It offers a broad array of analytical testing, process development, and manufacturing services to pharmaceutical and biotech companies at its facilities in San Antonio, Texas. Its analytical services include development of a comprehensive range of analytical test methods to characterize complex biologics, including cell therapy-based products, protein therapeutics, vaccines and advanced therapies. Its Clinical Biomanufacturing includes cGMP Mammalian Cell Culture, and cGMP Microbial Fermentation. Its San Antonio facility is focused on the commercial-scale manufacturing of biodefense-focused molecules and biologics therapeutics. Its biomanufacturing services focus on accelerating product development timelines from pre-clinical evaluation to first-in-human studies.
More about the company
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.111
Average target price
-
Consensus
  1. Stock Market
  2. Equities
  3. SCPX Stock
  4. Funds and ETFs Scorpius Holdings, Inc.